context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: | text | 7.5 | monetaryItemType | text: <entity> 7.5 </entity> <entity type> monetaryItemType </entity type> <context> Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: | text | 5.8 | monetaryItemType | text: <entity> 5.8 </entity> <entity type> monetaryItemType </entity type> <context> Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
Other activity during 2023 includes $ 0.3 million of reserves assumed by the Company with the acquisition of CD within the PD segment. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> Other activity during 2023 includes $ 0.3 million of reserves assumed by the Company with the acquisition of CD within the PD segment. </context> | us-gaap:ProductWarrantyAccrual |
During the year ended December 31, 2024, the Company recorded restructuring charges within the PD segment of $ 3.4 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations. The Company recorded $ 1.9 million in restructuring charges within "Gross profit" and the remaining $ 1.5 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2024. | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company recorded restructuring charges within the PD segment of $ 3.4 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations. The Company recorded $ 1.9 million in restructuring charges within "Gross profit" and the remaining $ 1.5 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2024. </context> | us-gaap:RestructuringCharges |
During the year ended December 31, 2023, the Company recorded restructuring charges within the PD segment of $ 2.5 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations, and $ 0.8 million for Corporate charges. The Company recorded $ 1.1 million in restructuring charges within "Gross profit" and the remaining $ 2.2 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2023. | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded restructuring charges within the PD segment of $ 2.5 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations, and $ 0.8 million for Corporate charges. The Company recorded $ 1.1 million in restructuring charges within "Gross profit" and the remaining $ 2.2 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2023. </context> | us-gaap:RestructuringCharges |
During the year ended December 31, 2023, the Company recorded restructuring charges within the PD segment of $ 2.5 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations, and $ 0.8 million for Corporate charges. The Company recorded $ 1.1 million in restructuring charges within "Gross profit" and the remaining $ 2.2 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2023. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded restructuring charges within the PD segment of $ 2.5 million for severance pay and benefits related to headcount reductions and for costs associated with transferring certain capacitors manufacturing to existing facilities to further optimize operations, and $ 0.8 million for Corporate charges. The Company recorded $ 1.1 million in restructuring charges within "Gross profit" and the remaining $ 2.2 million within "Operating expenses" on the Consolidated Statement of Earnings for the year ended December 31, 2023. </context> | us-gaap:RestructuringCharges |
To manage its exposure to foreign currency exchange rates, the Company has entered into currency deliverable forward contracts. These derivative instruments allow the Company to hedge portions of its forecasted funding needs, which are generally expected to occur within the next twelve months and are denominated in currencies other than the U.S. dollar. The Company maintains a foreign currency cash flow hedging program primarily to reduce the risk that the net U.S. dollar cash inflows and non-U.S. dollar net cash outflows will be adversely affected by changes in foreign currency exchange rates. At December 31, 2024 and 2023, the notional value of the derivatives related to currency forward contracts, principally the Chinese yuan, Malaysian ringgit, Philippine peso, Japanese yen, and Mexican peso was $ 43.4 million and $ 49.2 million, respectively. The Company presents the impact of foreign exchange contracts qualifying as cash flow hedges within "Cost of goods sold" on the Consolidated Statements of Earnings, which is the same line used to present the earnings effect of the hedged item. | text | 43.4 | monetaryItemType | text: <entity> 43.4 </entity> <entity type> monetaryItemType </entity type> <context> To manage its exposure to foreign currency exchange rates, the Company has entered into currency deliverable forward contracts. These derivative instruments allow the Company to hedge portions of its forecasted funding needs, which are generally expected to occur within the next twelve months and are denominated in currencies other than the U.S. dollar. The Company maintains a foreign currency cash flow hedging program primarily to reduce the risk that the net U.S. dollar cash inflows and non-U.S. dollar net cash outflows will be adversely affected by changes in foreign currency exchange rates. At December 31, 2024 and 2023, the notional value of the derivatives related to currency forward contracts, principally the Chinese yuan, Malaysian ringgit, Philippine peso, Japanese yen, and Mexican peso was $ 43.4 million and $ 49.2 million, respectively. The Company presents the impact of foreign exchange contracts qualifying as cash flow hedges within "Cost of goods sold" on the Consolidated Statements of Earnings, which is the same line used to present the earnings effect of the hedged item. </context> | us-gaap:DerivativeNotionalAmount |
To manage its exposure to foreign currency exchange rates, the Company has entered into currency deliverable forward contracts. These derivative instruments allow the Company to hedge portions of its forecasted funding needs, which are generally expected to occur within the next twelve months and are denominated in currencies other than the U.S. dollar. The Company maintains a foreign currency cash flow hedging program primarily to reduce the risk that the net U.S. dollar cash inflows and non-U.S. dollar net cash outflows will be adversely affected by changes in foreign currency exchange rates. At December 31, 2024 and 2023, the notional value of the derivatives related to currency forward contracts, principally the Chinese yuan, Malaysian ringgit, Philippine peso, Japanese yen, and Mexican peso was $ 43.4 million and $ 49.2 million, respectively. The Company presents the impact of foreign exchange contracts qualifying as cash flow hedges within "Cost of goods sold" on the Consolidated Statements of Earnings, which is the same line used to present the earnings effect of the hedged item. | text | 49.2 | monetaryItemType | text: <entity> 49.2 </entity> <entity type> monetaryItemType </entity type> <context> To manage its exposure to foreign currency exchange rates, the Company has entered into currency deliverable forward contracts. These derivative instruments allow the Company to hedge portions of its forecasted funding needs, which are generally expected to occur within the next twelve months and are denominated in currencies other than the U.S. dollar. The Company maintains a foreign currency cash flow hedging program primarily to reduce the risk that the net U.S. dollar cash inflows and non-U.S. dollar net cash outflows will be adversely affected by changes in foreign currency exchange rates. At December 31, 2024 and 2023, the notional value of the derivatives related to currency forward contracts, principally the Chinese yuan, Malaysian ringgit, Philippine peso, Japanese yen, and Mexican peso was $ 43.4 million and $ 49.2 million, respectively. The Company presents the impact of foreign exchange contracts qualifying as cash flow hedges within "Cost of goods sold" on the Consolidated Statements of Earnings, which is the same line used to present the earnings effect of the hedged item. </context> | us-gaap:DerivativeNotionalAmount |
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in non-functional currencies. The Company does not enter into these hedges for speculative reasons. These derivatives are carried at fair value with changes in fair value immediately recognized in earnings within Other expense (income), net. In addition, these derivative instruments minimize the impact of exchange rate movements on the Company’s balance sheet, as the gains or losses on these derivatives are intended to offset gains and losses from the reduction of the hedged assets and liabilities. At December 31, 2024 and 2023, the notional value of the derivatives related to economic hedging was $ 148.7 million and $ 111.7 million, respectively. | text | 148.7 | monetaryItemType | text: <entity> 148.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in non-functional currencies. The Company does not enter into these hedges for speculative reasons. These derivatives are carried at fair value with changes in fair value immediately recognized in earnings within Other expense (income), net. In addition, these derivative instruments minimize the impact of exchange rate movements on the Company’s balance sheet, as the gains or losses on these derivatives are intended to offset gains and losses from the reduction of the hedged assets and liabilities. At December 31, 2024 and 2023, the notional value of the derivatives related to economic hedging was $ 148.7 million and $ 111.7 million, respectively. </context> | us-gaap:DerivativeNotionalAmount |
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in non-functional currencies. The Company does not enter into these hedges for speculative reasons. These derivatives are carried at fair value with changes in fair value immediately recognized in earnings within Other expense (income), net. In addition, these derivative instruments minimize the impact of exchange rate movements on the Company’s balance sheet, as the gains or losses on these derivatives are intended to offset gains and losses from the reduction of the hedged assets and liabilities. At December 31, 2024 and 2023, the notional value of the derivatives related to economic hedging was $ 148.7 million and $ 111.7 million, respectively. | text | 111.7 | monetaryItemType | text: <entity> 111.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in non-functional currencies. The Company does not enter into these hedges for speculative reasons. These derivatives are carried at fair value with changes in fair value immediately recognized in earnings within Other expense (income), net. In addition, these derivative instruments minimize the impact of exchange rate movements on the Company’s balance sheet, as the gains or losses on these derivatives are intended to offset gains and losses from the reduction of the hedged assets and liabilities. At December 31, 2024 and 2023, the notional value of the derivatives related to economic hedging was $ 148.7 million and $ 111.7 million, respectively. </context> | us-gaap:DerivativeNotionalAmount |
The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax |
The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax |
The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> The table above excludes a tax benefit of $ 0.8 million, $ 1.1 million, and $ 0.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax |
On February 8, 2023, the Company entered into an Amended and Restated Credit Agreement (the "A&R Credit Agreement") that amends and restates the prior Credit Agreement, dated September 4, 2020, and provides for a senior secured revolving credit facility with borrowings in an aggregate principal amount at any time outstanding not to exceed $ 400.0 million (the "Credit Facility"). The A&R Credit Agreement, among other things, extends the maturity date of the Credit Facility from January 2, 2024 to February 8, 2028, replaces the London Inter-Bank Offered Rate (“LIBOR”) with the Term Secured Overnight Financing Rate (“Term SOFR”) as a reference rate available for borrowings, amends the minimum Interest Coverage Ratio, and amends certain other financial covenants with which the Company must comply, as described below. | text | 400.0 | monetaryItemType | text: <entity> 400.0 </entity> <entity type> monetaryItemType </entity type> <context> On February 8, 2023, the Company entered into an Amended and Restated Credit Agreement (the "A&R Credit Agreement") that amends and restates the prior Credit Agreement, dated September 4, 2020, and provides for a senior secured revolving credit facility with borrowings in an aggregate principal amount at any time outstanding not to exceed $ 400.0 million (the "Credit Facility"). The A&R Credit Agreement, among other things, extends the maturity date of the Credit Facility from January 2, 2024 to February 8, 2028, replaces the London Inter-Bank Offered Rate (“LIBOR”) with the Term Secured Overnight Financing Rate (“Term SOFR”) as a reference rate available for borrowings, amends the minimum Interest Coverage Ratio, and amends certain other financial covenants with which the Company must comply, as described below. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On September 25, 2023, the Company amended its A&R Credit Agreement to, among other things, (a) permit the Company in connection with the acquisition of CD, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of $ 122.9 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Cornell Dubilier, LLC (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Cornell Dubilier, LLC and the acquired subsidiaries that constitute Acquisition Assets from exceeding $ 80.0 million in the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023. | text | 122.9 | monetaryItemType | text: <entity> 122.9 </entity> <entity type> monetaryItemType </entity type> <context> On September 25, 2023, the Company amended its A&R Credit Agreement to, among other things, (a) permit the Company in connection with the acquisition of CD, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of $ 122.9 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Cornell Dubilier, LLC (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Cornell Dubilier, LLC and the acquired subsidiaries that constitute Acquisition Assets from exceeding $ 80.0 million in the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023. </context> | us-gaap:SecuredLongTermDebt |
On September 25, 2023, the Company amended its A&R Credit Agreement to, among other things, (a) permit the Company in connection with the acquisition of CD, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of $ 122.9 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Cornell Dubilier, LLC (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Cornell Dubilier, LLC and the acquired subsidiaries that constitute Acquisition Assets from exceeding $ 80.0 million in the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023. | text | 80.0 | monetaryItemType | text: <entity> 80.0 </entity> <entity type> monetaryItemType </entity type> <context> On September 25, 2023, the Company amended its A&R Credit Agreement to, among other things, (a) permit the Company in connection with the acquisition of CD, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of $ 122.9 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Cornell Dubilier, LLC (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Cornell Dubilier, LLC and the acquired subsidiaries that constitute Acquisition Assets from exceeding $ 80.0 million in the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. | text | 100.0 | monetaryItemType | text: <entity> 100.0 </entity> <entity type> monetaryItemType </entity type> <context> Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. | text | 0.225 | percentItemType | text: <entity> 0.225 </entity> <entity type> percentItemType </entity type> <context> Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. | text | 0.350 | percentItemType | text: <entity> 0.350 </entity> <entity type> percentItemType </entity type> <context> Up to $ 100.0 million of the Credit Facility will be available in Euro, Pounds Sterling, and other currencies requested by the Company and up to $ 50.0 million of the Credit Facility will be made available in the form of letters of credit. Undrawn amounts under the Credit Facility accrue a commitment fee at a per annum rate of 0.225 % to 0.350 %, based on a leverage ratio grid. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. | text | 1.50 | percentItemType | text: <entity> 1.50 </entity> <entity type> percentItemType </entity type> <context> The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. | text | 2.50 | percentItemType | text: <entity> 2.50 </entity> <entity type> percentItemType </entity type> <context> The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. | text | 1.50 | percentItemType | text: <entity> 1.50 </entity> <entity type> percentItemType </entity type> <context> The interest rates under the A&R Credit Facility will be, at the Borrowers' option (1) (A) in the case of borrowings denominated in U.S. dollars Term SOFR, (B) in the case of borrowings denominated in Sterling, Daily Simple Sonia, or (C) for borrowings denominated in Euro, EURIBOR, in each case, plus the rates per annum determined from time to time based on the total net leverage ratio of the Company as of the end of and for the most recent period of four fiscal quarters for which financial statements have been delivered (the "Applicable Margin"); or (2) in the case of borrowings denominated in U.S. dollars, alternate base rate ("ABR") (as defined in the A&R Credit Agreement) plus the Applicable Margin. The Applicable Margin for Term SOFR, Daily Simple Sonia, or EURIBOR could range from 1.50 % to 2.50 % while the Applicable Margin for ABR could range from 0.50 % to 1.50 %. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. | text | 7.07 | percentItemType | text: <entity> 7.07 </entity> <entity type> percentItemType </entity type> <context> The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. </context> | us-gaap:LongtermDebtWeightedAverageInterestRate |
The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. | text | 6.55 | percentItemType | text: <entity> 6.55 </entity> <entity type> percentItemType </entity type> <context> The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. </context> | us-gaap:LongtermDebtWeightedAverageInterestRate |
The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. | text | 3.21 | percentItemType | text: <entity> 3.21 </entity> <entity type> percentItemType </entity type> <context> The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. </context> | us-gaap:LongtermDebtWeightedAverageInterestRate |
The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. | text | 0.23 | percentItemType | text: <entity> 0.23 </entity> <entity type> percentItemType </entity type> <context> The weighted-average interest rate on the Company's borrowings under the Credit Facility and the 2020 Credit Facility was 7.07 %, 6.55 %, and 3.21 % for the years ended December 31, 2024, 2023, and 2022, respectively. The weighted-average commitment fee on the revolving lines of credit was 0.26 % for the years ended December 31, 2024 and 0.23 % for the years ended December 31, 2023 and 2022. </context> | us-gaap:LineOfCreditFacilityCommitmentFeePercentage |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 246.8 | monetaryItemType | text: <entity> 246.8 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 122.9 | monetaryItemType | text: <entity> 122.9 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 109.9 | monetaryItemType | text: <entity> 109.9 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 7.5 | monetaryItemType | text: <entity> 7.5 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:InterestExpenseDebt |
On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. | text | 1.3 | monetaryItemType | text: <entity> 1.3 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company completed the acquisition of CD for a total purchase price of $ 246.8 million. This acquisition was funded by borrowings on the Revolving Credit Facility and an interest-free note from the seller with aggregate principal payments of $ 122.9 million (the "Seller Note"). The Company repaid $ 50.0 million of the Seller Note on November 1, 2024 and the remaining $ 72.7 million balance on the seller Note is due and payable in cash on November 1, 2025. On the acquisition date, the Company recorded the Seller Note at its present value of $ 109.9 million by discounting the future principal payments using an imputed rate of interest of approximately 7.1 % in accordance with accounting guidance in ASC 835, Interest. During the year ended December 31, 2024, the Company made an indemnity claim against the Seller Note of $ 0.2 million. The Company recognized imputed interest expense on the Seller Note of approximately $ 7.5 million and $ 1.3 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:InterestExpenseDebt |
In the 2016, the Company entered into warrant transactions, whereby the Company sold warrants to acquire shares of the Company's common stock at a strike price of $ 21.1050 per share (the “Warrants”). The Company received aggregate proceeds of $ 39.1 million from the sale of the Warrants. The Warrants were separate transactions entered into by the Company and were accounted for as part of additional paid-in capital. | text | 21.1050 | perShareItemType | text: <entity> 21.1050 </entity> <entity type> perShareItemType </entity type> <context> In the 2016, the Company entered into warrant transactions, whereby the Company sold warrants to acquire shares of the Company's common stock at a strike price of $ 21.1050 per share (the “Warrants”). The Company received aggregate proceeds of $ 39.1 million from the sale of the Warrants. The Warrants were separate transactions entered into by the Company and were accounted for as part of additional paid-in capital. </context> | us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 |
In the 2016, the Company entered into warrant transactions, whereby the Company sold warrants to acquire shares of the Company's common stock at a strike price of $ 21.1050 per share (the “Warrants”). The Company received aggregate proceeds of $ 39.1 million from the sale of the Warrants. The Warrants were separate transactions entered into by the Company and were accounted for as part of additional paid-in capital. | text | 39.1 | monetaryItemType | text: <entity> 39.1 </entity> <entity type> monetaryItemType </entity type> <context> In the 2016, the Company entered into warrant transactions, whereby the Company sold warrants to acquire shares of the Company's common stock at a strike price of $ 21.1050 per share (the “Warrants”). The Company received aggregate proceeds of $ 39.1 million from the sale of the Warrants. The Warrants were separate transactions entered into by the Company and were accounted for as part of additional paid-in capital. </context> | us-gaap:ProceedsFromIssuanceOfWarrants |
The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. | text | 48.7 | monetaryItemType | text: <entity> 48.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. | text | 25.5 | monetaryItemType | text: <entity> 25.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. | text | 23.2 | monetaryItemType | text: <entity> 23.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded valuation allowances of $ 48.7 million and $ 25.5 million at December 31, 2024 and 2023, respectively, against deferred tax assets from continuing operations as the Company believes it is more likely than not that these assets will not be realized. At December 31, 2024, we recognized an income tax benefit of $ 23.2 million (primarily through discontinued operations) related to the accrual of the deferred tax asset valuation allowance on our foreign net operating losses and U.S. state tax attributes. The Company routinely reviews the future realization of deferred tax assets based on projected future reversal of taxable temporary differences, available tax planning strategies, and projected future taxable income. Management believes that it is more likely than not that the Company will realize the benefits of the remaining deferred tax assets. </context> | us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount |
At December 31, 2024, the Company had $ 3.1 million of U.S. federal net operating losses that are available, of which $ 3.1 million will expire in the next 6 to 10 years. There are $ 3.1 million of domestic State net operating losses that are available between 2027 and 2043. There are $ 283.1 million of non-U.S. net operating loss carryforwards, of which $ 2.6 million will expire in the next 5 years; $ 0.3 million will expire in the next 6 to 10 years; $ 279.5 million will expire in the next 11 to 20 years; $ 0.6 million can be carried forward indefinitely; and $ 0.1 million is a capital loss carried forward indefinitely. | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company had $ 3.1 million of U.S. federal net operating losses that are available, of which $ 3.1 million will expire in the next 6 to 10 years. There are $ 3.1 million of domestic State net operating losses that are available between 2027 and 2043. There are $ 283.1 million of non-U.S. net operating loss carryforwards, of which $ 2.6 million will expire in the next 5 years; $ 0.3 million will expire in the next 6 to 10 years; $ 279.5 million will expire in the next 11 to 20 years; $ 0.6 million can be carried forward indefinitely; and $ 0.1 million is a capital loss carried forward indefinitely. </context> | us-gaap:OperatingLossCarryforwards |
At December 31, 2024, the Company had $ 3.1 million of U.S. federal net operating losses that are available, of which $ 3.1 million will expire in the next 6 to 10 years. There are $ 3.1 million of domestic State net operating losses that are available between 2027 and 2043. There are $ 283.1 million of non-U.S. net operating loss carryforwards, of which $ 2.6 million will expire in the next 5 years; $ 0.3 million will expire in the next 6 to 10 years; $ 279.5 million will expire in the next 11 to 20 years; $ 0.6 million can be carried forward indefinitely; and $ 0.1 million is a capital loss carried forward indefinitely. | text | 283.1 | monetaryItemType | text: <entity> 283.1 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company had $ 3.1 million of U.S. federal net operating losses that are available, of which $ 3.1 million will expire in the next 6 to 10 years. There are $ 3.1 million of domestic State net operating losses that are available between 2027 and 2043. There are $ 283.1 million of non-U.S. net operating loss carryforwards, of which $ 2.6 million will expire in the next 5 years; $ 0.3 million will expire in the next 6 to 10 years; $ 279.5 million will expire in the next 11 to 20 years; $ 0.6 million can be carried forward indefinitely; and $ 0.1 million is a capital loss carried forward indefinitely. </context> | us-gaap:OperatingLossCarryforwards |
The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. | text | 22.2 | monetaryItemType | text: <entity> 22.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. | text | 8.6 | monetaryItemType | text: <entity> 8.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. | text | 15.9 | monetaryItemType | text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. | text | 2.2 | monetaryItemType | text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. | text | 13.7 | monetaryItemType | text: <entity> 13.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company has $ 22.2 million of U.S. federal research and development credits that begin to expire in 2025 and $ 8.6 million of foreign tax credits that begin to expire in 2027. In addition, the Company has $ 15.9 million of state credits, of which $ 2.2 million will expire between 2025 and 2039 if unused, and $ 13.7 million can be carried forward indefinitely. </context> | us-gaap:TaxCreditCarryforwardAmount |
As of December 31, 2024, the Company has approximately $ 1.5 billion of undistributed earnings in its foreign subsidiaries. Approximately $ 0.3 billion of these earnings are no longer considered permanently reinvested. The incremental tax cost to repatriate these earnings to the U.S. is immaterial. The Company has not provided for deferred taxes on approximately $ 1.2 billion of undistributed earnings from non-U.S. subsidiaries which are indefinitely reinvested in operations. If these earnings were distributed, they would likely not be subject to U.S. federal income tax because they were previously taxed under the Tax Reform Act. We would likely be required to accrue and pay U.S. state and local taxes and withholding taxes payable to various countries. It is not practical to determine the income tax liability that would be payable if such earnings were not reinvested indefinitely. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company has approximately $ 1.5 billion of undistributed earnings in its foreign subsidiaries. Approximately $ 0.3 billion of these earnings are no longer considered permanently reinvested. The incremental tax cost to repatriate these earnings to the U.S. is immaterial. The Company has not provided for deferred taxes on approximately $ 1.2 billion of undistributed earnings from non-U.S. subsidiaries which are indefinitely reinvested in operations. If these earnings were distributed, they would likely not be subject to U.S. federal income tax because they were previously taxed under the Tax Reform Act. We would likely be required to accrue and pay U.S. state and local taxes and withholding taxes payable to various countries. It is not practical to determine the income tax liability that would be payable if such earnings were not reinvested indefinitely. </context> | us-gaap:UndistributedEarningsOfForeignSubsidiaries |
The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued |
The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued |
The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company records interest and penalties associated with unrecognized tax benefits as a component of income tax expense. During the years ended December 31, 2024, 2023, and 2022, the Company recorded interest expense resulting in insignificant balances. The Company recorded penalty expense during the years ended December 31, 2024 and 2022 resulting in accrued penalties of $ 0.3 million and $ 0.1 million, respectively, which were included in Other liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2023, the Company recorded no penalty expense. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued |
Included in the balance of total unrecognized tax benefits at December 31, 2024 are potential benefits of $ 1.6 million, which if recognized, would affect the effective rate on earnings from continuing operations. Given the Company's current valuation allowance position, no benefit is expected to result from the reversal of any uncertain tax position associated with the acquired attributes. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> Included in the balance of total unrecognized tax benefits at December 31, 2024 are potential benefits of $ 1.6 million, which if recognized, would affect the effective rate on earnings from continuing operations. Given the Company's current valuation allowance position, no benefit is expected to result from the reversal of any uncertain tax position associated with the acquired attributes. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company maintains equity compensation plans that provide for the issuance of Knowles stock to directors, executive officers, and other employees. The maximum number of shares available for issuance under the plans is 23.4 million, of which 13.1 million were available for future awards at December 31, 2024. | text | 23.4 | sharesItemType | text: <entity> 23.4 </entity> <entity type> sharesItemType </entity type> <context> The Company maintains equity compensation plans that provide for the issuance of Knowles stock to directors, executive officers, and other employees. The maximum number of shares available for issuance under the plans is 23.4 million, of which 13.1 million were available for future awards at December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company maintains equity compensation plans that provide for the issuance of Knowles stock to directors, executive officers, and other employees. The maximum number of shares available for issuance under the plans is 23.4 million, of which 13.1 million were available for future awards at December 31, 2024. | text | 13.1 | sharesItemType | text: <entity> 13.1 </entity> <entity type> sharesItemType </entity type> <context> The Company maintains equity compensation plans that provide for the issuance of Knowles stock to directors, executive officers, and other employees. The maximum number of shares available for issuance under the plans is 23.4 million, of which 13.1 million were available for future awards at December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
Unrecognized compensation expense related to stock options not yet exercisable at December 31, 2024 was $ 0.1 million. The remaining cost is expected to be recognized over a weighted-average period of 0.1 years. | text | 0.1 | monetaryItemType | text: <entity> 0.1 </entity> <entity type> monetaryItemType </entity type> <context> Unrecognized compensation expense related to stock options not yet exercisable at December 31, 2024 was $ 0.1 million. The remaining cost is expected to be recognized over a weighted-average period of 0.1 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
RSUs vest based on the passage of time. Generally, RSUs have a three year vesting schedule and vest one-third on each of the first three anniversaries of the grant date. The fair value of RSUs vested during the year ended December 31, 2024 was $ 17.5 million. At December 31, 2024, $ 17.6 million of unrecognized compensation expense related to RSUs is expected to be recognized over a weighted-average period of 1.6 years. | text | 17.5 | monetaryItemType | text: <entity> 17.5 </entity> <entity type> monetaryItemType </entity type> <context> RSUs vest based on the passage of time. Generally, RSUs have a three year vesting schedule and vest one-third on each of the first three anniversaries of the grant date. The fair value of RSUs vested during the year ended December 31, 2024 was $ 17.5 million. At December 31, 2024, $ 17.6 million of unrecognized compensation expense related to RSUs is expected to be recognized over a weighted-average period of 1.6 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
RSUs vest based on the passage of time. Generally, RSUs have a three year vesting schedule and vest one-third on each of the first three anniversaries of the grant date. The fair value of RSUs vested during the year ended December 31, 2024 was $ 17.5 million. At December 31, 2024, $ 17.6 million of unrecognized compensation expense related to RSUs is expected to be recognized over a weighted-average period of 1.6 years. | text | 17.6 | monetaryItemType | text: <entity> 17.6 </entity> <entity type> monetaryItemType </entity type> <context> RSUs vest based on the passage of time. Generally, RSUs have a three year vesting schedule and vest one-third on each of the first three anniversaries of the grant date. The fair value of RSUs vested during the year ended December 31, 2024 was $ 17.5 million. At December 31, 2024, $ 17.6 million of unrecognized compensation expense related to RSUs is expected to be recognized over a weighted-average period of 1.6 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. | text | eight | integerItemType | text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected |
For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. | text | 2.4 | integerItemType | text: <entity> 2.4 </entity> <entity type> integerItemType </entity type> <context> For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected |
For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. | text | 227812 | sharesItemType | text: <entity> 227812 </entity> <entity type> sharesItemType </entity type> <context> For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. | text | 150811 | sharesItemType | text: <entity> 150811 </entity> <entity type> sharesItemType </entity type> <context> For the awards granted in February 2019 (the “2019 PSUs”), the number of PSUs that may be earned and vest was originally based on the Company's revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award was based on the Company’s revenues and TSR relative to the component companies of the S&P Semiconductor Select Industry Index over three separate one-year performance periods to isolate the impact of the COVID-19 pandemic on the Company's fiscal 2020 performance. Each period was weighted equally, as the Company expected to face challenges related to the COVID-19 pandemic in fiscal 2021. Service conditions were not modified. The modification of the 2019 PSUs affected eight employees and resulted in total incremental compensation expense of $ 2.4 million, which was recognized over the remaining service period. Incremental compensation expense was subject to adjustment for the achievement of the performance condition based on fiscal 2021 revenues. In February 2022, the 2019 PSUs were converted from 227,812 PSUs to 150,811 shares of common stock based on achievement of the modified conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. | text | eight | integerItemType | text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected |
For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. | text | 4.7 | integerItemType | text: <entity> 4.7 </entity> <entity type> integerItemType </entity type> <context> For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected |
For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. | text | 261770 | sharesItemType | text: <entity> 261770 </entity> <entity type> sharesItemType </entity type> <context> For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. | text | 120677 | sharesItemType | text: <entity> 120677 </entity> <entity type> sharesItemType </entity type> <context> For the awards granted in February 2020 (the “2020 PSUs”), the number of PSUs that may be earned and vest was originally based on TSR relative to the component companies of the S&P Semiconductor Select Industry Index over a three-year performance period. The modified award replaces the S&P Semiconductor Select Industry Index with the Russell 2000 Index. The Company is a member of the Russell 2000 Index, which represents a broader, more diversified index that better aligns with the Company's strategy. Service conditions were not modified. The modification of the 2020 PSUs affected eight employees and resulted in total incremental compensation expense of $ 4.7 million, which was recognized over the remaining service period. In February 2023, the 2020 PSUs were converted from 261,770 PSUs to 120,677 shares of common stock based on achievement of the modification conditions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod |
The fair value of PSUs vested during the year ended December 31, 2024 was $ 3.8 million. At December 31, 2024, $ 9.1 million of unrecognized compensation expense related to PSUs is expected to be recognized over a weighted-average period of 1.3 years. | text | 3.8 | monetaryItemType | text: <entity> 3.8 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of PSUs vested during the year ended December 31, 2024 was $ 3.8 million. At December 31, 2024, $ 9.1 million of unrecognized compensation expense related to PSUs is expected to be recognized over a weighted-average period of 1.3 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The fair value of PSUs vested during the year ended December 31, 2024 was $ 3.8 million. At December 31, 2024, $ 9.1 million of unrecognized compensation expense related to PSUs is expected to be recognized over a weighted-average period of 1.3 years. | text | 9.1 | monetaryItemType | text: <entity> 9.1 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of PSUs vested during the year ended December 31, 2024 was $ 3.8 million. At December 31, 2024, $ 9.1 million of unrecognized compensation expense related to PSUs is expected to be recognized over a weighted-average period of 1.3 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 5.5 | monetaryItemType | text: <entity> 5.5 </entity> <entity type> monetaryItemType </entity type> <context> Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 5.2 | monetaryItemType | text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 4.9 | monetaryItemType | text: <entity> 4.9 </entity> <entity type> monetaryItemType </entity type> <context> Knowles sponsors its own defined contribution plans. The Company's expense relating to defined contribution plans was $ 5.5 million, $ 5.2 million, and $ 4.9 million on a continuing operations basis for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:DefinedContributionPlanCostRecognized |
Generally, annual contributions are made at such times and in such amounts as required by law and agreed with the trustees of the non-U.S. defined benefit plans. The Company estimates it will pay $ 0.8 million during the year ended December 31, 2025 related to contributions to these plans. This amount may vary based on updated funding agreements with the trustees of these plans. | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> Generally, annual contributions are made at such times and in such amounts as required by law and agreed with the trustees of the non-U.S. defined benefit plans. The Company estimates it will pay $ 0.8 million during the year ended December 31, 2025 related to contributions to these plans. This amount may vary based on updated funding agreements with the trustees of these plans. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
For the year ended December 31, 2024, the cumulative foreign currency translation loss in other comprehensive loss includes a $ 3.4 million | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> For the year ended December 31, 2024, the cumulative foreign currency translation loss in other comprehensive loss includes a $ 3.4 million </context> | us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax |
For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. | text | 0.7 | sharesItemType | text: <entity> 0.7 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. | text | 1.9 | sharesItemType | text: <entity> 1.9 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. | text | 2.4 | sharesItemType | text: <entity> 2.4 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023, and 2022, the weighted-average number of anti-dilutive potential common shares for stock-based awards excluded from the calculation of diluted earnings per share above was 0.7 million, 1.9 million, and 2.4 million, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of December 31, 2024, Parent owned approximately 97 % of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3 % of the outstanding Omega OP Units. | text | 97 | percentItemType | text: <entity> 97 </entity> <entity type> percentItemType </entity type> <context> Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of December 31, 2024, Parent owned approximately 97 % of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3 % of the outstanding Omega OP Units. </context> | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of December 31, 2024, Parent owned approximately 97 % of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3 % of the outstanding Omega OP Units. | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega's assets are owned directly or indirectly by, and all of Omega's operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of December 31, 2024, Parent owned approximately 97 % of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3 % of the outstanding Omega OP Units. </context> | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. | text | 7.3 | monetaryItemType | text: <entity> 7.3 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. </context> | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. </context> | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. | text | 3.2 | monetaryItemType | text: <entity> 3.2 </entity> <entity type> monetaryItemType </entity type> <context> Real estate properties are carried at initial recorded value less accumulated depreciation. The costs of significant improvements, renovations and replacements, including interest are capitalized. Our interest expense reflected in the Consolidated Statements of Operations has been reduced by the amounts capitalized. For the years ended December 31, 2024, 2023 and 2022, we capitalized $ 7.3 million, $ 4.3 million and $ 3.2 million, respectively, of interest to our projects under development. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are expensed as they are incurred. </context> | us-gaap:RealEstateInventoryCapitalizedInterestCosts |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 15.5 | monetaryItemType | text: <entity> 15.5 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 1.9 | monetaryItemType | text: <entity> 1.9 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 52.7 | monetaryItemType | text: <entity> 52.7 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 36.0 | monetaryItemType | text: <entity> 36.0 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 29.1 | monetaryItemType | text: <entity> 29.1 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. | text | 27.1 | monetaryItemType | text: <entity> 27.1 </entity> <entity type> monetaryItemType </entity type> <context> We obtain liquidity deposits and other deposits, security deposits and letters of credit from certain operators pursuant to our lease and mortgage agreements. These generally represent the rental and/or mortgage interest for periods ranging from three to six months with respect to certain of our investments or the required deposits in connection with our HUD borrowings. At December 31, 2024 and 2023, we held $ 15.5 million and $ 1.9 million, respectively, in liquidity and other deposits and $ 52.7 million and $ 36.0 million, respectively, in security deposits. We also had the ability to draw on $ 29.1 million and $ 27.1 million of letters of credit at December 31, 2024 and 2023, respectively. </context> | us-gaap:SecurityDeposit |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. | text | 10.4 | monetaryItemType | text: <entity> 10.4 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. </context> | us-gaap:AmortizationOfFinancingCosts |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. | text | 13.7 | monetaryItemType | text: <entity> 13.7 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. </context> | us-gaap:AmortizationOfFinancingCosts |
External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. | text | 12.9 | monetaryItemType | text: <entity> 12.9 </entity> <entity type> monetaryItemType </entity type> <context> External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. Any difference between fair value and stated value of debt, assumed in an assets acquisition or business combination, is recorded as a discount or premium and amortized over the remaining term of the loan. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Net amortization of deferred financing costs and premiums or discounts totaled $ 10.4 million, $ 13.7 million and $ 12.9 million for the years ended December 31, 2024, 2023 and 2022, respectively, and are recorded in interest expense on our Consolidated Statements of Operations. </context> | us-gaap:AmortizationOfFinancingCosts |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. | text | 0.10 | perShareItemType | text: <entity> 0.10 </entity> <entity type> perShareItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. </context> | us-gaap:CommonStockParOrStatedValuePerShare |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. | text | 97 | percentItemType | text: <entity> 97 </entity> <entity type> percentItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. </context> | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> The noncontrolling interest for Omega primarily represents the outstanding Omega OP Units held by outside investors. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $ 0.10 per share (“Omega Common Stock”), subject to Omega’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one -for-one basis, subject to adjustment as set forth in Omega OP’s partnership agreement. As of December 31, 2024, Omega owns approximately 97 % of the issued and outstanding Omega OP Units, and investors own approximately 3 % of the outstanding Omega OP Units. </context> | us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. | text | 93.6 | monetaryItemType | text: <entity> 93.6 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:Revenues |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. | text | 56.8 | monetaryItemType | text: <entity> 56.8 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:Revenues |
The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. | text | 47.7 | monetaryItemType | text: <entity> 47.7 </entity> <entity type> monetaryItemType </entity type> <context> The U.S. dollar (“USD”) is the functional currency for our consolidated subsidiaries operating in the U.S. The functional currency for our consolidated subsidiaries operating in the U.K. is the British Pound (“GBP”). Total revenues from our consolidated U.K. operating subsidiaries were $ 93.6 million, $ 56.8 million and $ 47.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. Our consolidated U.K. operating subsidiaries held long-lived assets of $ 1.1 billion and $ 539.6 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:Revenues |
Certain amounts in the prior year period have been reclassified to conform to the current period presentation. Income from direct financing leases, which was previously reported separately on our Consolidated Statements of Operations, is now included in rental income for all periods presented. In addition, we previously reported assets held for sale of $ 93.7 million on the Consolidated Balance Sheet as of December 31, 2023. In the first quarter of 2024 and the fourth quarter of 2024, it was determined that $ 12.2 million and $ 14.4 million, respectively, of these assets no longer qualified as held for sale and were reclassified to assets held for use within the applicable line items in real estate assets – net on the Consolidated Balance Sheet as of December 31, 2023. Of the $ 26.6 million reclassified net of $ 11.1 million of accumulated depreciation, $ 30.9 million relates to buildings, $ 3.4 million relates to land and $ 3.4 million relates to furniture and equipment. | text | 93.7 | monetaryItemType | text: <entity> 93.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain amounts in the prior year period have been reclassified to conform to the current period presentation. Income from direct financing leases, which was previously reported separately on our Consolidated Statements of Operations, is now included in rental income for all periods presented. In addition, we previously reported assets held for sale of $ 93.7 million on the Consolidated Balance Sheet as of December 31, 2023. In the first quarter of 2024 and the fourth quarter of 2024, it was determined that $ 12.2 million and $ 14.4 million, respectively, of these assets no longer qualified as held for sale and were reclassified to assets held for use within the applicable line items in real estate assets – net on the Consolidated Balance Sheet as of December 31, 2023. Of the $ 26.6 million reclassified net of $ 11.1 million of accumulated depreciation, $ 30.9 million relates to buildings, $ 3.4 million relates to land and $ 3.4 million relates to furniture and equipment. </context> | us-gaap:RealEstateHeldforsale |
On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extended the practical expedients under ASU 2020-04 to December 31, 2024. The Company had several derivative instruments that referenced LIBOR which were terminated during the second quarter of 2023 (see Note 15 – Derivatives and Hedging). The Company also had a $ 1.45 billion senior unsecured multicurrency revolving credit facility and a $ 50.0 million senior unsecured term loan facility (see Note 14 – Borrowing Activities and Arrangements) that referenced LIBOR. During the second quarter of 2023, the Company amended its $ 1.45 billion senior unsecured multicurrency revolving credit facility and $ 50.0 million senior unsecured term loan facility to adjust the interest on each loan from a LIBOR based interest rate to a Secured Overnight Financing Rate (“SOFR”) based interest rate. For both loans we have elected to apply the optional expedient pursuant to Topic 848. As such we will account for the amendments as if the modifications were not substantial and thus a continuation of the existing contract resulting in no change to the current loan carrying values or the related deferred financing costs. | text | 1.45 | monetaryItemType | text: <entity> 1.45 </entity> <entity type> monetaryItemType </entity type> <context> On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extended the practical expedients under ASU 2020-04 to December 31, 2024. The Company had several derivative instruments that referenced LIBOR which were terminated during the second quarter of 2023 (see Note 15 – Derivatives and Hedging). The Company also had a $ 1.45 billion senior unsecured multicurrency revolving credit facility and a $ 50.0 million senior unsecured term loan facility (see Note 14 – Borrowing Activities and Arrangements) that referenced LIBOR. During the second quarter of 2023, the Company amended its $ 1.45 billion senior unsecured multicurrency revolving credit facility and $ 50.0 million senior unsecured term loan facility to adjust the interest on each loan from a LIBOR based interest rate to a Secured Overnight Financing Rate (“SOFR”) based interest rate. For both loans we have elected to apply the optional expedient pursuant to Topic 848. As such we will account for the amendments as if the modifications were not substantial and thus a continuation of the existing contract resulting in no change to the current loan carrying values or the related deferred financing costs. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extended the practical expedients under ASU 2020-04 to December 31, 2024. The Company had several derivative instruments that referenced LIBOR which were terminated during the second quarter of 2023 (see Note 15 – Derivatives and Hedging). The Company also had a $ 1.45 billion senior unsecured multicurrency revolving credit facility and a $ 50.0 million senior unsecured term loan facility (see Note 14 – Borrowing Activities and Arrangements) that referenced LIBOR. During the second quarter of 2023, the Company amended its $ 1.45 billion senior unsecured multicurrency revolving credit facility and $ 50.0 million senior unsecured term loan facility to adjust the interest on each loan from a LIBOR based interest rate to a Secured Overnight Financing Rate (“SOFR”) based interest rate. For both loans we have elected to apply the optional expedient pursuant to Topic 848. As such we will account for the amendments as if the modifications were not substantial and thus a continuation of the existing contract resulting in no change to the current loan carrying values or the related deferred financing costs. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, which extended the practical expedients under ASU 2020-04 to December 31, 2024. The Company had several derivative instruments that referenced LIBOR which were terminated during the second quarter of 2023 (see Note 15 – Derivatives and Hedging). The Company also had a $ 1.45 billion senior unsecured multicurrency revolving credit facility and a $ 50.0 million senior unsecured term loan facility (see Note 14 – Borrowing Activities and Arrangements) that referenced LIBOR. During the second quarter of 2023, the Company amended its $ 1.45 billion senior unsecured multicurrency revolving credit facility and $ 50.0 million senior unsecured term loan facility to adjust the interest on each loan from a LIBOR based interest rate to a Secured Overnight Financing Rate (“SOFR”) based interest rate. For both loans we have elected to apply the optional expedient pursuant to Topic 848. As such we will account for the amendments as if the modifications were not substantial and thus a continuation of the existing contract resulting in no change to the current loan carrying values or the related deferred financing costs. </context> | us-gaap:OtherLoansPayable |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. | text | 49 | percentItemType | text: <entity> 49 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. | text | 63 | integerItemType | text: <entity> 63 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. | text | 97.6 | monetaryItemType | text: <entity> 97.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, we held a 49 % interest in an unconsolidated real estate joint venture owning 63 facilities in the U.K. (the “Cindat Joint Venture”) accounted for using the equity method of accounting. As of December 31, 2023, our equity interest was $ 97.6 million. The 63 facilities are subject to leases with two operators that have contractual rent of $ 43.6 million per annum with minimum escalators between 1.0 % to 2.0 % that can escalate further based on certain inflationary measures. </context> | us-gaap:EquityMethodInvestments |
In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £ 188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair value of $ 264.0 million and (iii) deferred contingent consideration of $ 2.0 million that was paid in December 2024. The fair market value of the mortgage debt assumed was determined by discounting the remaining contractual cash flows using a current market rate of interest of comparable debt instruments. | text | 98.9 | monetaryItemType | text: <entity> 98.9 </entity> <entity type> monetaryItemType </entity type> <context> In July 2024, we acquired the remaining 51 % interest in the Cindat Joint Venture for total consideration of $ 364.9 million inclusive of: (i) $ 98.9 million of cash consideration including direct transaction costs, (ii) the assumption of a £ 188.6 million mortgage loan (the “2026 Mortgage Loan”) with an estimated fair value of $ 264.0 million and (iii) deferred contingent consideration of $ 2.0 million that was paid in December 2024. The fair market value of the mortgage debt assumed was determined by discounting the remaining contractual cash flows using a current market rate of interest of comparable debt instruments. </context> | us-gaap:PaymentsToAcquireInterestInJointVenture |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.